AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
9.81
+0.16 (1.66%)
Jun 9, 2026, 4:00 PM EDT - Market closed
AdaptHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,287 | 3,245 | 3,261 | 3,200 | 2,971 | 2,455 | |
Revenue Growth (YoY) | 1.24% | -0.49% | 1.90% | 7.73% | 21.02% | 132.35% |
Cost of Revenue | 2,687 | 2,636 | 2,580 | 2,576 | 2,390 | 2,009 |
Gross Profit | 600.26 | 609.2 | 681.09 | 624.07 | 580.12 | 445.61 |
Selling, General & Admin | 391.35 | 382.29 | 359.24 | 334.59 | 324.81 | 167.51 |
Depreciation & Amortization Expenses | 40.33 | 40.64 | 45.05 | 57.09 | 64.89 | 63.1 |
Other Operating Expenses | 128 | 128 | 13.08 | 830.79 | - | - |
Total Operating Expenses | 559.67 | 550.93 | 417.36 | 1,222 | 389.7 | 230.6 |
Operating Income | 73.19 | 90.87 | 263.73 | -598.4 | 190.41 | 225.61 |
Interest Expense | -102.95 | -105.75 | -126.67 | -130.3 | -109.41 | -95.2 |
Other Non-Operating Income (Expense) | 32.88 | 32.88 | -3.5 | -4.92 | -16.91 | -100.93 |
Total Non-Operating Income (Expense) | -70.07 | -72.88 | -130.17 | -135.22 | -126.32 | -196.12 |
Pretax Income | -30.03 | -15.15 | 136.02 | -723.78 | 97.9 | 190.96 |
Provision for Income Taxes | -1.69 | 50.88 | 41.24 | -49 | 24.77 | 32.81 |
Net Income | -74.83 | -66.04 | 94.78 | -674.78 | 73.13 | 158.15 |
Minority Interest in Earnings | 4.8 | 4.76 | 4.36 | 4.12 | 3.82 | 1.98 |
Net Income to Common | -16.04 | -70.79 | 90.42 | -678.9 | 69.32 | 156.18 |
Net Income Growth | - | - | - | - | -55.62% | - |
Shares Outstanding (Basic) | 135 | 135 | 134 | 134 | 147 | 126 |
Shares Outstanding (Diluted) | 136 | 135 | 136 | 134 | 210 | 133 |
Shares Change (YoY) | 0.30% | -0.28% | 0.83% | -36.01% | 57.89% | 153.46% |
EPS (Basic) | -0.61 | -0.52 | 0.62 | -5.06 | 0.47 | 1.12 |
EPS (Diluted) | -0.62 | -0.52 | 0.61 | -5.31 | 0.33 | 0.67 |
EPS Growth | - | - | - | - | -50.75% | - |
Shares Outstanding | 136.01 | 132.52 | 131.67 | 132.64 | 134.44 | 133.84 |
Free Cash Flow | 191.95 | 219.38 | 235.78 | 143.2 | -17.56 | 72.37 |
Free Cash Flow Growth | -12.50% | -6.96% | 64.65% | - | - | -53.57% |
Free Cash Flow Per Share | 1.41 | 1.62 | 1.74 | 1.07 | -0.08 | 0.54 |
Gross Margin | 18.26% | 18.77% | 20.89% | 19.50% | 19.53% | 18.15% |
Operating Margin | 2.23% | 2.80% | 8.09% | -18.70% | 6.41% | 9.19% |
Profit Margin | -2.28% | -2.04% | 2.91% | -21.09% | 2.46% | 6.44% |
FCF Margin | 5.84% | 6.76% | 7.23% | 4.47% | -0.59% | 2.95% |
EBITDA | 467.24 | 472.8 | 629.07 | -215.62 | 541.59 | 483.66 |
EBITDA Margin | 14.22% | 14.57% | 19.29% | -6.74% | 18.23% | 19.70% |
EBIT | 73.19 | 90.87 | 263.73 | -598.4 | 190.41 | 225.61 |
EBIT Margin | 2.23% | 2.80% | 8.09% | -18.70% | 6.41% | 9.19% |
Effective Tax Rate | 5.62% | -335.78% | 30.32% | 6.77% | 25.30% | 17.18% |